Work

ASH Highlights and Commentary: Additional Topics of Interest

Year: 2021

Type: editorial

Abstract: Dr. Tinsley provides insight for APs on the use of pevonedistat, a new small-molecule inhibitor. Dr. Kurtin considers the use of the CRISPR technique to detect COVID-19 in patients with hematologic malignancies and data from a retrospective observational cohort study describing the disease burden of primary cold agglutinin disease.

Source: Journal of the Advanced Practitioner in Oncology

DOI: 10.6004/jadpro.2021.12.3.30

Authors: Sara Tinsley, PhD, APRN, AOCN®, Sandra E. Kurtin, PhD, ANP-C, AOCN

Language: English

Topic: Hematological disorders and diagnostics

Subfield: Emergency Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3155005843

Cites:

Cited by:

Related to: 10